Matches in Nanopublications for { ?s ?p "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP236764.RAg0ntHurFgLATU_kmCRrmuRrZeQh1428K_7cCFIPVgaM130_assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236764.RAg0ntHurFgLATU_kmCRrmuRrZeQh1428K_7cCFIPVgaM130_provenance.
- NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_provenance.
- NP340449.RAegAcynfY-XHjYZfMaFj7wMR4E53xGLozgNkVuihQk8A130_assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340449.RAegAcynfY-XHjYZfMaFj7wMR4E53xGLozgNkVuihQk8A130_provenance.
- NP340286.RA6_4GPeKfj1jse5txIxQmM6yhqPMfDDnUTupbnt4iGJs130_assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340286.RA6_4GPeKfj1jse5txIxQmM6yhqPMfDDnUTupbnt4iGJs130_provenance.
- assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP324343.RAyDzEV07sRVroC_Gf4eBKIl7qsyVeh1l3c3UZYGTcxcE130_assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324343.RAyDzEV07sRVroC_Gf4eBKIl7qsyVeh1l3c3UZYGTcxcE130_provenance.
- NP324345.RAsRHMoOhYN0FYSKDuZJlcgAtfkOECRBnHLkpjW5IyVSM130_assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324345.RAsRHMoOhYN0FYSKDuZJlcgAtfkOECRBnHLkpjW5IyVSM130_provenance.